Afatinib Completed Phase 2 Trials for Neoplasms Metastasis / Neoplasms, Breast Treatment

CompletedTreatment2 IdentifierTitleDrugs
NCT00431067Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy
NCT01441596Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
NCT008262676 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or Trastuzumab
NCT00708214BIBW 2992 and Letrozole in Hormonoresistant Metastatic Breast Cancer